Volume 26, Number 9—September 2020
Research
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France
Table 6
ID | Prenatal corticosteroid, GA, wk, d† | Prenatal magnesium sulfate, GA, wk, d† | Time from diagnosis to delivery, d | Mode of delivery | GA at birth, wk, d | Birthweight, g (z-score) | 5-min Apgar score | Umbilical arterial pH | Neonatal intubation | NICU |
---|---|---|---|---|---|---|---|---|---|---|
1 | NA | 29 | 2 | Cesarean | 29 | 1,400 (1.10) | 7 | 7.26 | Y | Y |
2 | NA | NA | 8 | Cesarean | 39, 1 | 3,290 (0.06) | 10 | 7.21 | N | N |
3 | 30, 1 | 30+1 | 11 | Cesarean | 30, 2 | 1,500 (0.75) | 8 | 7.25 | Y | Y |
4 | 26, 4 | 26+4 | 7 | Cesarean | 27, 1 | 1,010 (0.82) | 1 | 7.28 | Y | Y |
5 | 26, 1 | 26, 4 | 7 | Cesarean | 27, 6 | 890 (−0.83) | 3 | 7.24 | Y | Y |
6 | NA | NA | 1 | Cesarean | 40, 6 | 3,570 (0.18) | 3 | ND | N | N |
7 | NA | 23, 5 | Ongoing pregnancy | NA | NA | NA | NA | NA | NA | NA |
8 | NA | 29, 4 | Ongoing pregnancy | NA | NA | NA | NA | NA | NA | NA |
9 | NA | NA | 1 | Cesarean | 36, 1 | 2,940 (0.49) | 10 | ND | N | N |
10 | 26, 6 | 27, 1 | 3 | Cesarean | 27, 2 | 1,065 (1.12) | 10 | 7.27 | Y | Y |
*All neonates tested negative for SARS-CoV-2. GA, gestational age; NA, not applicable; ND, not done; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
†At time of drug administration.
Page created: July 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.